Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one
2. Da 1229
3. Da-1229
4. Da1229
1. Da-1229
2. Evogliptin [inn]
3. 1222102-29-5
4. Chembl1779710
5. Evogliptin (inn)
6. Da1229
7. (r)-4-((r)-3-amino-4-(2,4,5-trifluorophenyl)-butanoyl)-3-(t-butoxymethyl)-piperazin-2-one
8. (r)-4-((r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one
9. 2-piperazinone, 4-((3r)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-3-((1,1-dimethylethoxy)methyl)-, (3r)-
10. 09118300l7
11. (r)-4-((r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazine-2-one
12. Unii-09118300l7
13. Evogliptin [who-dd]
14. Schembl343846
15. Dtxsid00153545
16. Bdbm50344779
17. Db12625
18. Hy-117985
19. Cs-0068793
20. C92448
21. D11023
22. Q25103700
23. (r)-4-[(r)-3-amino-4-(2,4,5-trifluorophenyl) Butanoyl]-3-(t-butoxymethyl)piperazin-2-one
24. (r)-4-[(r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(t-butoxymethy)piperazin-2-one
25. (3r)-4-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(tert-butoxymethyl)piperazin-2-one
26. (3r)-4-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one
27. (r)-4-[(r)-3-amino-4-(2,4,5-trifluorophenyl) Butanoyl]-3-(t-butoxymethyl)piperazine-2-one
28. 8vu
Molecular Weight | 401.4 g/mol |
---|---|
Molecular Formula | C19H26F3N3O3 |
XLogP3 | 1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 7 |
Exact Mass | 401.19262619 g/mol |
Monoisotopic Mass | 401.19262619 g/mol |
Topological Polar Surface Area | 84.7 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 558 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
A - Alimentary tract and metabolism
A10 - Drugs used in diabetes
A10B - Blood glucose lowering drugs, excl. insulins
A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors
A10BH07 - Evogliptin
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
43
PharmaCompass offers a list of Evogliptin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Evogliptin manufacturer or Evogliptin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Evogliptin manufacturer or Evogliptin supplier.
PharmaCompass also assists you with knowing the Evogliptin API Price utilized in the formulation of products. Evogliptin API Price is not always fixed or binding as the Evogliptin Price is obtained through a variety of data sources. The Evogliptin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 09118300L7 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 09118300L7, including repackagers and relabelers. The FDA regulates 09118300L7 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 09118300L7 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 09118300L7 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 09118300L7 supplier is an individual or a company that provides 09118300L7 active pharmaceutical ingredient (API) or 09118300L7 finished formulations upon request. The 09118300L7 suppliers may include 09118300L7 API manufacturers, exporters, distributors and traders.
click here to find a list of 09118300L7 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 09118300L7 Drug Master File in Korea (09118300L7 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 09118300L7. The MFDS reviews the 09118300L7 KDMF as part of the drug registration process and uses the information provided in the 09118300L7 KDMF to evaluate the safety and efficacy of the drug.
After submitting a 09118300L7 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 09118300L7 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 09118300L7 suppliers with KDMF on PharmaCompass.
09118300L7 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 09118300L7 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 09118300L7 GMP manufacturer or 09118300L7 GMP API supplier for your needs.
A 09118300L7 CoA (Certificate of Analysis) is a formal document that attests to 09118300L7's compliance with 09118300L7 specifications and serves as a tool for batch-level quality control.
09118300L7 CoA mostly includes findings from lab analyses of a specific batch. For each 09118300L7 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
09118300L7 may be tested according to a variety of international standards, such as European Pharmacopoeia (09118300L7 EP), 09118300L7 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (09118300L7 USP).